Caricamento...
Prediction model for hyperprogressive disease in non‐small cell lung cancer treated with immune checkpoint inhibitors
BACKGROUND: Hyperprogressive disease (HPD) is a paradoxical acceleration of tumor growth after immune checkpoint inhibitor (ICI) treatment. This study aimed to identify the risk factors and to present a predictive model for HPD in patients treated with ICIs. METHODS: A total of 78 non‐small cell lun...
Salvato in:
| Pubblicato in: | Thorac Cancer |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons Australia, Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529559/ https://ncbi.nlm.nih.gov/pubmed/32779394 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13594 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|